Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5958159 | 0.77 | ALDH1A1 (0.44) | ALDH1A1CYP2C19 | |
| SCHEMBL11767025 | 0.77 | ALDH1A1 (0.53) | ALDH1A1CYP2C19 | |
| SCHEMBL20618378 | 0.74 | ALDH1A1 (0.50) | ALDH1A1CYP2C19 | |
| SCHEMBL11480141 | 0.72 | ALDH1A1 (0.39) | ALDH1A1CYP2C19 | |
| SCHEMBL14569223 | 0.72 | ALDH1A1 (0.39) | ALDH1A1CYP2C19 | |
| SCHEMBL13212309 | 0.72 | ALDH1A1 (0.39) | ALDH1A1CYP2C19 | |
| SCHEMBL22975 | 0.70 | — | — | |
| SCHEMBL48154 | 0.70 | — | — | |
| SCHEMBL8403281 | 0.69 | ALDH1A1 (0.44) | ALDH1A1CYP2C19 | |
| SCHEMBL2575275 | 0.67 | ALDH1A1 (0.50) | ALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572303-B2 | A symmetrical dialkyl carbonate, a metal, borong, silicon, or group 7 compound, a hydrogen or hydrocarbon-based fuel, an oxidizer, and a metallic cocatalyst; minimized hydrolysis; improved combustion and storage stability | OCTANE INTERNATIONAL, LTD. (US) | 2009-08-11 | — | — | US | claimed |
| EP-0954558-B1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 2006-06-14 | — | — | EP | claimed |
| US-20050044778-A1 | Fuel compositions employing catalyst combustion structure | OCTANE INTERNATIONAL, LTD. | 2005-03-03 | — | — | US | claimed |
| US-20040237384-A1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2004-12-02 | — | — | US | claimed |
| US-6652608-B1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2003-11-25 | — | — | US | claimed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | claimed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | claimed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | claimed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | claimed |
| CN-115894380-A | N-aryl substituted imino ester compound and preparation method and application thereof | 上海特化医药科技有限公司 | 2023-04-04 | — | — | CN | disclosed |
| US-20180222906-A1 | SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES COMPANY | 2018-08-09 | — | — | US | disclosed |
| US-9938275-B2 | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-04-10 | — | — | US | disclosed |
| US-20170129891-A1 | SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES CO (US) | 2017-05-11 | — | — | US | disclosed |
| US-9550773-B2 | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-01-24 | — | — | US | disclosed |
| US-4576936-A | ANTINFLAMMATORY | STEROSYNT LTD. (GB) | 1986-03-18 | — | — | US | disclosed |
| US-4358445-A | ANTIINFLAMMATORY AGENT | STEROSYNT LTD. (GB) | 1982-11-09 | — | — | US | disclosed |
| US-4096257-A | ANTIASTHMATIC; ENZYME INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4021459-A | Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes | SCHERING CORPORATION (US) | 1977-05-03 | — | — | US | disclosed |
| US-3992422-A | Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes | SCHERING CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
| US-3980680-A | Process for the preparation of 21-desoxy-17-acyloxy-4-pregnenes and of 21-iodo-21-desoxy-17-acyl oxy-4-pregnene intermediates useful therein | SCHERING CORPORATION (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222906-A1 | SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES | IL2, IFNG, IL4 | ALDH1A1 2159/4885CYP2C19 3386/4885 |
| US-20170129891-A1 | SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES | IL2, IFNG, IL4 | ALDH1A1 2159/4885CYP2C19 3386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.